Author:
Gesierich Anja,Schilling Bastian
Publisher
Springer Berlin Heidelberg
Reference52 articles.
1. Arits AH, Mosterd K, Essers BA et al (2013) Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomized controlled trial. Lancet Onkol 14(7):647–654
2. Basset-Seguin N, Hauschild A, Grob JJ et al (2015) Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial. Lancet Oncol 16(6):729–736
3. Becker JC, Eigentler T, Frerich B et al (2018) S2k-Leitlinie-Merkelzellkarzinom (MZK, MCC, neuroendokrines Karzinom der Haut) – Update 2018 Registernummer 032-023. https://www.awmf.org/leitlinien/detail/ll/032-023.html. Zugegriffen am 04.11.2021
4. Behshad R, Garcia-Zuazaga J, Bordeaux JS (2011) Systemic treatment of locally advanced nonmetastatic cutaneous squamous cell carcinoma: a review of the literature. Br J Dermatol 165(6):1169–1177
5. Blauvelt A, Kempers S, Lain E et al (2021) Phase 3 trial of tirbanibulin ointment for actinic keratosis. N Engl J Med 284:512–520